Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Presented for research literature review only Siler-Khodr TM et al
1), scientists have begun to explore GLP-1 therapeutics as possible treatments for substance use disorders
WHY USE
Background There were two GLP-1 products that were initially approved and marketed for treating type-2 diabetes but, because they also had successful weight loss results, the manufacturers each got FDA approval to sell the products under two separate indications, one indicated for type 2 diabetes and one for weight loss, each with its own brand name and National Drug Code (NDC) identification number
